March 6, 2020
Mayo Clinic in the News Weekly Highlights for March 6, 2020
By Emily Blahnik
TIME, You Can Learn a Lot About Yourself From a DNA Test. Here’s What Your Genes Cannot Tell You by Libby Copeland — …What is a consumer to believe? A few years ago, Helix, originally a spin-out of genomics giant Illumina (which makes many of the chips and machines used to analyze DNA), unveiled a […]
View full entry
Tags: Adam Francis, alzheimer's disease, Angel Eye, arthritis, brain aneurysm, brain tumors, Breast Cancer, Caring Canines, Clinic Data Analytics, colon polyps Dr. Darin Presser, concussions, coronavirus
September 1, 2017
Mayo Clinic in the News Weekly Highlights
By Karl Oestreich
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Editor, Karl Oestreich; Assistant Editor: Emily Blahnik Star Tribune Gut bacteria may play role in fighting MS, Mayo researcher […]
View full entry
Tags: ActionNewsJax, advisory board, altitude sickness, Alyssa Sandeen, Alzforum, American Medical Association, Amyloidosis, Anatomage, Atlanta Journal-Constitution, atrial fibrillation, ayo Clinic Health System-Franciscan Healthcare, Becker’s Hospital Review
August 5, 2016
Mayo Clinic in the News Weekly Highlights
By Karl Oestreich
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich; Assistant Editor: Emily Blahnik Washington Post A “breathholding time” for Alzheimer’s research as trials […]
View full entry
Tags: Albert Lea Tribune, Allentown Morning Call, alzheimer's disease, Arcadia, Best Hospitals, Boston Magazine, Breast Cancer, Bring Me the News, calorie intake, CBS News, Chippewa Herald, concussions
January 2, 2013
The Future of Medicine Is Now
By Logan Lafferty
In our era of instant gratification, the world of medicine seems like an outlier. The path from a promising discovery to an effective treatment often takes a decade or more…After years of controversy, gene therapy is poised to become a viable option for a variety of often life-threatening medical conditions, especially those resulting from a […]
View full entry
Tags: blindness, defective gene, gene therapy, Glybera, heart failure, hemophelia, molecular medicine, Stephen J. Russell, Wall Street Journal